Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $213.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 26.85% to $213.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $213.9 million, a 26.85% increase, with the full-year FY2025 number at $213.9 million, up 26.85% from a year prior.
  • Total Non-Current Liabilities was $213.9 million for Q4 2025 at GeneDx Holdings, up from -$296.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $407.6 million in Q2 2021 to a low of -$296.5 million in Q3 2025.
  • A 5-year average of $169.6 million and a median of $182.9 million in 2025 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: surged 146.71% in 2021, then plummeted 255.34% in 2024.
  • GeneDx Holdings' Total Non-Current Liabilities stood at $144.1 million in 2021, then soared by 47.98% to $213.2 million in 2022, then fell by 17.45% to $176.0 million in 2023, then fell by 4.2% to $168.6 million in 2024, then grew by 26.85% to $213.9 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Total Non-Current Liabilities are $213.9 million (Q4 2025), -$296.5 million (Q3 2025), and $183.5 million (Q2 2025).